News

Sword Health Expands Bloom Into a Full Life-Stage Women’s Health Platform, Launches Menopause Program

GalCare Launches First Automated Sanitary Pad Factory in Kenya with Enterprise Model to Combat Period Poverty

iMerit, Segmed, and Advocate Health Release Open-Source 3D Mammography Dataset for AI Research

Ultrasound AI Receives FDA De Novo Clearance for AI-Powered Delivery Date Prediction

Mamava Partners with SimpliFed to Offer Virtual Lactation Consulting Directly via App

28x Launches with £1.2M in Funding for Free, Privacy-First Period Tracking and Women’s Health App

Flo Health Publishes Economic Evaluation of a Digital Symptom Checker for Endometriosis

Pregnolia Secures $4.4M Backed by European Innovation Council to Advance Preterm Birth Diagnostics

YOU(th) Health Tech Raises $4.5M for Smartphone-Based Preventive Health Screening

Gedeon Richter Acquires Celmatix’s Women’s Health Drug Discovery Portfolio

AI in Women’s Health: Native Build vs. Feature Bolt-on

Carea Launches Digital IVF and Egg Freezing Support Tool for Women Between Clinic Visits

Evvy Identifies Six Distinct Subtypes of Bacterial Vaginosis After Sequencing 100,000+ Samples

South Korean Menstrual Care Company Inertia Enters U.S. Market with Plant-Based Period Pad Technology

Kindbody Founder Gina Bartasi Launches YourJOY.ai, an AI-Native Fertility Platform

Samsung Next Makes Strategic Investment in Nucleus Genomics

The State of Male Contraception: What’s Actually in the Pipeline – and Why It Matters for Women’s Health

Reprotech and EngagedMD Partner to Digitize Off-Site Storage Consents for Fertility Clinics

“This Is Endometriosis” Wins BAFTA for Best British Short Film

Oura Launches Proprietary AI Model Built Specifically for Women’s Health

Bonafide Health Launches Noctera, a Hormone-Free Sleep Supplement for Menopausal Women

Carrot Adds On-Demand Pediatric Telemedicine to Its Benefits Platform Through Blueberry Pediatrics

Alamar Biosciences Launches Blood-Based 5-Plex Assay for Alzheimer’s Disease Research

NEXT Life Sciences Advances Two Male Contraceptives Into Phase II Trials